ArticleCancer chemotherapy and pharmacology2022

Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies.

Maarten van Eijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.